Building a Resilient Quantum Patent Portfolio: Winning the Race to File First

​
May 29, 2025

A key question for those working in a fast-paced and complex industry such as quantum technology is when to patent any technological developments. The earlier the filing date of the patent application, the earlier you can start to talk about your invention openly, to potential investors, customers, or other companies seeking to collaborate to commercialise the invention. However, speed is not the sole requirement to win the race: to truly succeed, your patent must be robust too.

A particular challenge of quantum technology is that there can be a significant delay between devising the initial inventive concept and rigorous proof that the invention actually works in practice. At what point should you file your patent application?

There are numerous factors to consider, including how rapidly the technology is evolving and the current priorities of your business, given the funds available. In this article, we will focus on the requirement for patent applications to include a sufficiently detailed explanation of how to carry out the invention, and how this ties into considerations around when to file for patent protection. We will also discuss a sufficiency case study in quantum computing.

Requirement of Sufficiency

The patent process involves a trade-off: the patentee can prevent others from carrying out their invention for a limited amount of time but, in exchange, they must describe how the invention can be performed. Ironing out the details of a working implementation in order to meet this requirement of sufficiency can take a significant amount of time. This means that patentees must tread a delicate path between getting a patent application on file as soon as they can, without filing the application so early that they are unable to fully describe how the invention works.

These issues are particularly relevant for emerging technologies, such as quantum technologies, for which there may be a long road from initial idea to a working prototype, let alone to a commercial product, and where the understanding of the physics underlying an innovative concept is often significantly ahead of the understanding of how to implement the innovative concept in practice. For innovators seeking to change the status quo, there will naturally be a desire to get ahead of the curve by patenting innovative concepts as soon as possible. This could lead to businesses opting to patent before working implementations are fully pinned down, potentially leading to patents that are invalid due to lack of sufficiency.

While a description of a plausible way of putting the invention into effect will usually satisfy patent office examiners, issues relating to sufficiency tend to appear when you least want them to, for example during a due diligence exercise for an investment or for a joint venture opportunity, when the issue of sufficiency may be investigated in more detail. We may therefore see an uptick in sufficiency issues arising for quantum tech patents as the technology matures, and as dealmaking increases within the field.

Certain sufficiency issues can't be fixed after a patent application is filed, and a granted patent that insufficiently describes how to perform the invention may be effectively unenforceable and vulnerable to revocation. It is therefore vital to ensure that the technology to implement an innovative concept is adequately understood and described in the patent application at the time of filing. If there is any uncertainty over how to implement an innovative concept in practice, then there is a risk involved in filing a patent application at that time. Whether it is worthwhile taking that risk involves weighing up the level of uncertainty against the possible benefits of filing early.

Sufficiency Case Study: Topological Qubits

The unveiling by Microsoft in February 2025 of the self-proclaimed "world's first quantum processor powered by topological qubits"[1] raises interesting questions around the validity of patent applications directed towards topological qubits that were filed before this date.

A quick search of published patent applications in the name of Microsoft that mention a "topological qubit" in the title or abstract reveals at least 16 patent families with an earliest effective filing date of before February 2025, with some families filed well before this date. For example, US patent number 8,748,196 has a priority date of way back in November 2010 and includes claims referring to a topological qubit.

Even now, there is debate within the quantum community about whether the structure presented in the Microsoft Nature paper[2] that accompanied the February 2025 announcement is truly a topological qubit or whether it is instead an Andreev state. Particular caution may be merited given Microsoft's previous pronouncements in this space: they were forced to retract a 2018 Nature paper[3] that claimed evidence of topological qubits due to self-confessed "insufficient scientific rigour".

If it is eventually discovered that the structure described in Microsoft's February 2025 Nature paper is not a topological qubit, there is a significant question mark over whether it would have been possible to produce topological qubits claimed in earlier patents based on the description in these earlier patents and the general knowledge in the field at the time of filing. Put another way, if it weren't possible to implement topological qubits as late as February 2025, how would it be possible for patents filed earlier than this to include a description of a working implementation of topological qubits? If this were the case, the validity of patents filed earlier than February 2025 that claim topological qubits would be in serious doubt.

There is also a more philosophical question regarding the meaning of the term "qubit". To distinguish a qubit from e.g. an arbitrary two-level quantum system, there is a sense that a qubit must be (i) preparable into a given state, (ii) controllable into other states, and (iii) measurable. If the techniques for any of (i)-(iii) are non-trivial or not yet well established within the field, then a patent application describing a novel two-level quantum system which could in principle serve as a qubit may not be able to make a claim to a qubit per se without running into sufficiency issues.

For nascent quantum technologies in which companies are seeking foundational patents, striking a balance between future promise and concrete, demonstrated implementation is essential. Otherwise, we could see sufficiency issues making a dramatic impact on the patent landscape, for example if key patents for a particular technology are held to be invalid due to insufficiency.

Conclusion

We expect to see sufficiency play an increasingly prominent part in the assessment of validity of patents in the quantum technology space. Choosing the right moment to patent your innovation in this field will be important to obtain resilient protection that can withstand deep scrutiny and third-party challenges. If you would like to discuss protecting your IP in the quantum technology arena or how to optimise your patent filing strategy, please do get in touch with our Quantiphy team.

[1] Microsoft unveils Majorana 1, the world's first quantum processor powered by topological qubits - Microsoft Azure Quantum Blog

[2]Interferometric single-shot parity measurement in InAs–Al hybrid devices | Nature

[3]Retraction Note: Quantized Majorana conductance | Nature

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Quantum IP Strategy: Own control Points, Not Patent Counts
14 October 2026
In quantum, the strongest portfolios will not be the biggest. Stuart Malcolm sets out six moves for owning the control points the market cannot route around, and the questions investors will ask.
#
Consulting
​
Targeted, Not Transformative: The UKIPO’s Considered Course on SEPs
13 October 2026
Andrew Sharples analyses the UKIPO's response to its SEP consultation, exploring proposed changes to FRAND dispute resolution, SEP transparency and licensing guidance, and what they mean for SEP holders and implementers.
#
Consulting
​
Chinese Companies in European Patent Litigation
30 September 2026
Chinese companies are becoming increasingly active in European patent litigation, both as defendants and as patent owners enforcing their own rights. This article examines the growing role of Europe and the Unified Patent Court (UPC) in global patent disputes, highlighting key cases involving Chinese businesses and the strategic opportunities and risks that come with operating in European markets. It is the first in a series exploring the practical implications of European patent enforcement for Chinese companies.
#
Patenting
​
How to mitigate prior art traps for follow-on pharma patents
27 August 2026
Follow-on patents are increasingly important for pharmaceutical innovators. Learn how new EMA clinical trial disclosure rules create prior art risks and discover practical strategies to protect pharmaceutical IP and maximise patent value.
#
Consulting
​
Chinese companies and the UPC: from enforcement targets to strategic users
13 August 2026
Chinese companies are playing an increasingly significant role in UPC litigation, accounting for around 38% of infringement actions in 2025. While many remain defendants, a growing number are actively using the Unified Patent Court to enforce their own patent rights across Europe. The trend highlights the UPC's rising importance for Chinese businesses operating in sectors such as telecommunications, semiconductors, medical devices and renewable energy, and signals a shift in global patent enforcement strategy.
#
Patenting
​
Evaluating the environmental impact of patent AI.
31 July 2026
AI's environmental impact is rarely out of the headlines, but how does it compare to the benefits it delivers in practice? In this article, Laurence Brown examines the energy use of AI-assisted patent drafting, comparing it with traditional drafting workflows. While measuring AI's true environmental footprint is far from straightforward, the analysis suggests that AI-assisted patent drafting may already be more energy efficient, while delivering significant productivity gains for patent professionals.
#
Patenting
​
UPC appeals after three years: Early indications on appeal success rates
15 July 2026
Three years into the UPC, appeal overturn rates sit at 56% for both substantive and preliminary injunction cases, with Kodak v Fujifilm among the rulings reshaping outcomes on appeal.
#
Litigation
​
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
#
Litigation
​
Podcast: Building an AI-Native Law Firm
26 June 2026
On the Technically Legal podcast, EIP partner Laurence Brown discusses how Visser AI is redesigning patent workflows, letting the firm offer fixed fees without trading away speed or quality.
#
Patenting
​
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
#
Litigation
​
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
#
Consulting
​
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
#
Consulting
​
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
#
Consulting
​
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
#
Patenting
​
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
#
Patenting
​